Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, Ontario M5T 3M7, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), 250 College St., Toronto, Ontario M5T 1R8, Canada; Department of Psychiatry, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada; Institute of Medical Science (IMS), University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada; Institut für Klinische Psychologie und Psychotherapie, Technische Universität Dresden, Chemnitzer Str. 46, 01187 Dresden, Germany; Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Bol'shaya Pirogovskaya Ulitsa, 19с1, Moscow 119146, Russia.
J Subst Abuse Treat. 2021 Oct;129:108374. doi: 10.1016/j.jsat.2021.108374. Epub 2021 Mar 19.
Closures and reductions in capacity of select health and social services in response to the COVID-19 pandemic may have placed people who use drugs (PWUD) at a disproportionately increased risk for experiencing harms, and resulted in critical treatment disruptions. We conducted the current national study among a cohort of PWUD to understand how COVID-19 has affected service access, including any significant impacts PWUD may have experienced. Results will contribute to the evidence base for informing future pandemic and public health policy planning for vulnerable populations.
The project involved qualitative telephone-based interviews with 196 adult (aged 18+) PWUD from across Canada. Eligibility criteria included daily or weekly use of psychoactive substance(s), and/or current enrollment in opioid agonist treatment (OAT). Data collection took place between May and July 2020. Data underwent thematic analyses, and common themes informed the results.
Most participants experienced detrimental service access issues and treatment disruptions during COVID-19, including reduced access to harm reduction services, OAT, withdrawal management and treatment services, medical professionals (e.g., addictions and mental health counseling), shelters/housing, and food banks. Positive impacts included greater access to OAT take-home 'carries' and prescription deliveries. Decreases in service capacity resulted in increased health issues and risky substance use behaviors among PWUD, such as unaccompanied substance use, sharing/re-use of supplies, and overdose events.
Reductions in the accessibility of critical services PWUD rely on during COVID-19 has increased existent substance use and health issues among PWUD, while decreasing their ability to mitigate risks related to substance use. Thus, the expansion of the depth and breadth of support options is crucial. Services must remain open and flexible to the unique needs of PWUD during COVID-19, while novel and effective adaptations and interventions should remain available and accessible post-COVID-19.
为应对 COVID-19 大流行,一些卫生和社会服务机构关闭并缩减了服务规模,这可能使吸毒者面临不成比例的更高风险,并导致关键治疗中断。我们在吸毒者队列中进行了这项全国性研究,以了解 COVID-19 如何影响服务的可及性,包括吸毒者可能经历的任何重大影响。研究结果将为为弱势群体提供未来大流行和公共卫生政策规划提供依据。
该项目涉及对来自加拿大各地的 196 名成年(年龄在 18 岁及以上)吸毒者进行基于电话的定性访谈。入选标准包括每日或每周使用精神活性物质,和/或当前正在接受阿片类激动剂治疗(OAT)。数据收集于 2020 年 5 月至 7 月进行。数据进行了主题分析,共同主题为结果提供了信息。
大多数参与者在 COVID-19 期间经历了有害的服务获取问题和治疗中断,包括减少获得减少伤害服务、OAT、戒断管理和治疗服务、医疗专业人员(如成瘾和心理健康咨询)、住所/住房和食品银行。积极的影响包括更多地获得 OAT 带回家的“携带物”和处方药交付。服务能力的下降导致吸毒者出现更多的健康问题和危险的物质使用行为,例如无人陪伴的物质使用、供应品的共享/再利用以及过量事件。
COVID-19 期间,吸毒者赖以获得的关键服务的可及性降低,增加了吸毒者现有的物质使用和健康问题,同时降低了他们减轻与物质使用相关风险的能力。因此,扩大支持选项的深度和广度至关重要。在 COVID-19 期间,服务必须保持开放和灵活,以满足吸毒者的独特需求,同时在 COVID-19 之后,应保持提供新颖有效的适应和干预措施。